LEVERAGED SHORT CERTIFICATE - PFIZER INC Stock

Certificat

SPFI5S

DE000SH101K7

Real-time Borsa Italiana 10:05:18 2024-06-03 EDT
31.1 EUR -13.85% Intraday chart for LEVERAGED SHORT CERTIFICATE - PFIZER INC
1 month-55.49%
3 months-51.54%
Date Price Change
24-06-03 31.1 -13.85%
24-05-31 36.1 -6.84%
24-05-30 38.75 -5.83%
24-05-29 41.15 +9.09%
24-05-28 37.72 +12.36%

Real-time Borsa Italiana

Last update June 03, 2024 at 10:05 am

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer Société Générale Société Générale
SPFI5S
ISINDE000SH101K7
Date issued 2022-01-26
Maturity Unlimited
Parity 1 : 1
Emission price 20
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 98.62
Lowest since issue 5.46
Spread 0.55
Spread %1.53%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66 USD
Average target price
31.92 USD
Spread / Average Target
+11.36%
Consensus
  1. Stock Market
  2. Certificates
  3. SPFI5S Certificat